BSSP (Cantech Holding) Market Cap: $0.00 Mil (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cantech Holding Market Cap?

Cantech Holding BSSP -99.50% Market Cap is $0.00 Mil as of Aug. 19, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cantech Holding's share price for the quarter that ended in Sep. 2015 was $0.0021. Cantech Holding's Shares Outstanding (EOP) for the quarter that ended in Sep. 2015 was 57.44 Mil. Therefore, Cantech Holding's market cap for the quarter that ended in Sep. 2015 was $0.12 Mil.

Cantech Holding's quarterly market cap increased from Mar. 2015 ($4.25 Mil) to Jun. 2015 ($5.18 Mil) but then declined from Jun. 2015 ($5.18 Mil) to Sep. 2015 ($0.12 Mil).

Cantech Holding's annual market cap increased from Dec. 2012 ($66.26 Mil) to Dec. 2013 ($105.04 Mil) but then declined from Dec. 2013 ($105.04 Mil) to Dec. 2014 ($18.46 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cantech Holding's Enterprise Value for Today is $0.00 Mil.


Cantech Holding  (OTCPK:BSSP) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Cantech Holding Market Cap Related Terms


Cantech Holding Market Cap Historical Data

* Premium members only.

The historical data trend for Cantech Holding's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantech Holding Market Cap Chart

Cantech Holding Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Market Cap
0.00 66.26 105.04 18.46

Cantech Holding Quarterly Data
Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.44 18.46 4.25 5.18 0.12

BSSP vs HSTC, NTRR, TLOG: Market Cap Comparison

For the Biotechnology subindustry, Cantech Holding's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantech Holding Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantech Holding's Market Cap distribution charts can be found below:

* The bar in red indicates where Cantech Holding's Market Cap falls into.



Cantech Holding Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cantech Holding's Market Cap for the fiscal year that ended in Dec. 2014 is calculated as

Market Cap (A: Dec. 2014 )=Share Price (A: Dec. 2014 )*Shares Outstanding (EOP) (A: Dec. 2014 )
=$0.499*36.998
=$18.46

Cantech Holding's Market Cap for the quarter that ended in Sep. 2015 is calculated as

Market Cap (Q: Sep. 2015 )=Share Price (Q: Sep. 2015 )*Shares Outstanding (EOP) (Q: Sep. 2015 )
=$0.0021*57.439
=$0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
Cantech Holding (BSSP) has a Market Cap of $0.00 Mil as of Aug. 19, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cantech Holding and its competitors.
Is Cantech Holding's Market Cap too high?
Cantech Holding's current Market Cap is $0.00 Mil.
How does Cantech Holding's Market Cap compare to HSTC and NTRR?
Cantech Holding's Market Cap of $0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 117.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.56, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cantech Holding and its competitors. For the Biotechnology industry, the median Market Cap is 117.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantech Holding's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantech Holding stock overvalued right now?
Cantech Holding (BSSP) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cantech Holding (BSSP), the current Market Cap is $0.00 Mil as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantech Holding Business Description

Address 120 W Pomona Avenue, Monrovia, CA, USA, 91016
Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company's product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.